Evidence map›Paper›PMID 20153386›Full record

ArticleJournal of controlled release : official journal of the Controlled Release Society2010

Fibrin-mediated lentivirus gene transfer: implications for lentivirus microarrays.

Shruti D Raut, Pedro Lei, Roshan M Padmashali, Stelios T Andreadis

Open access · greenAbstract read
In one paragraph

Article in Journal of controlled release : official journal of the Controlled Release Society, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Localized lentivirus delivery via peptide interactions.Biotechnology and bioengineering · 2016
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Matrix-based gene delivery for tissue repair.Current opinion in biotechnology · 2013
    Review
  13. Polysaccharide-modified scaffolds for controlled lentivirus delivery in vitro and after spinal cord injury.Journal of controlled release : official journal of the Controlled Release Society · 2013
    Article
  14. Article
  15. Hydrogels for lentiviral gene delivery.Expert opinion on drug delivery · 2013
    Review
  16. Fibrin hydrogels for lentiviral gene delivery in vitro and in vivo.Journal of controlled release : official journal of the Controlled Release Society · 2012
    Article
  17. Article
  18. Engineering biomaterial systems to enhance viral vector gene delivery.Molecular therapy : the journal of the American Society of Gene Therapy · 2011
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Shruti D RautBioengineering Laboratory, Department of Chemical and Biological Engineering, University at Buffalo, State University of New York, Amherst, NY 14260, United States.
Pedro Lei
Roshan M Padmashali
Stelios T Andreadis
University at Buffalo, State University of New York · USCenter for Excellence in Education · US

Funding

Retroviral Gene Transfer to Epidermal Stem CellsR01EB000876 · NIBIB · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI ANDREADIS, STELIOS THEOHARIS · 2003 to 2007
$1.5M
NIBIB NIH HHS R01 EB000876NIBIB NIH HHS R01 EB 000876-01
6 · The paper itself

Abstract

We employed fibrin hydrogel as a bioactive matrix for lentivirus mediated gene transfer. Fibrin-mediated gene transfer was highly efficient and exhibited strong dependence on fibrinogen concentration. Efficient gene transfer was achieved with fibrinogen concentration between 3.75 and 7.5mg/ml. Lower fibrinogen concentrations resulted in diffusion of virus out of the gel while higher concentrations led to ineffective fibrin degradation by target cells. Addition of fibrinolytic inhibitors decreased gene transfer in a dose-dependent manner suggesting that fibrin degradation by target cells may be necessary for successful gene delivery. Under these conditions transduction may be limited only to cells interacting with the matrix thereby providing a method for spatially-localized gene delivery. Indeed, when lentivirus-containing fibrin microgels were spotted in an array format gene transfer was confined to virus-containing fibrin spots with minimal cross-contamination between neighboring sites. Collectively, our data suggest that fibrin may provide an effective matrix for spatially-localized gene delivery with potential applications in high-throughput lentiviral microarrays and in regenerative medicine.

Indexed as

FibrinGenesGenetic TherapyGene Transfer TechniquesHumansLentivirusFibrin

Identifiers

PMID20153386
PMCPMC2868957
OpenAlexW2002484822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.